MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing

Supera-CBD is a novel synthetic derivative of cannabidiol (CBD … without limitation: the effect that the reverse stock split may have on the price of MyMD’s common stock; MyMD’s ability to maintain …